Private Equity
RMG Global has closed its biopharma investment fund at $64 million. The fund is focused on biotherapeutics developed within the Israel-based FutuRx incubator, established by OrbiMed Israel, Johnson & Johnson Innovation and Takeda Ventures in cooperation with the Israel Innovation Authority.
2 min read · 08 April 2019
B Capital, a venture firm co-founded by Facebook co-founder Eduardo Saverin, has raised over $406 million for its second fund, according to an SEC filing. No target was listed in the document. With offices in Los Angeles, San Francisco, Singapore and New York, B Capital invests in tech companies.
1 min read · 08 April 2019
4 min read · 05 April 2019
San Francisco-based Enlitic, a medical startup, has secured $15 million in Series B funding. Marubeni led the round with participation from other investors that included Capitol Health.
1 min read · 05 April 2019
1 min read · 05 April 2019
2 min read · 05 April 2019
Boulder, Colorado-based Inscripta, a gene-editing startup, has raised $20 million in funding. The investors were Venrock, Foresite, Mérieux Développement, Paladin Capital Group, MLS Capital and NanoDimension.
1 min read · 04 April 2019
Giblib, a streaming media platform offering on-demand medical lectures and surgical videos, has raised $2.5 million in seed funding. The investors included Mayo Clinic, Venture Reality Fund, Wavemaker 360, USC Marshall Venture Fund and Michelson 20MM.
1 min read · 04 April 2019
HealthVerity Inc, a foundation for the rapid creation, exchange and management of healthcare and consumer data, has secured $25 million in Series C funding. Foresite Capital led the round with participation from other investors that included Flare Capital Partners and Greycroft Partners.
1 min read · 04 April 2019
Cambridge, Massachusetts-based Dyne Therapeutics, a new biotechnology company, has secured $50 million in Series A funding. The investors were Atlas Venture, Forbion and MPM Capital.
1 min read · 04 April 2019
